The Patent Finder

Terms ending in 2029

Pharmacyclics, Inc.

Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,906,954Selective Inhibitors of Histone Deacetylase
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 7,820,711Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 9,107,924Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 9,795,605Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 8,883,435Inhibitors of Bruton's Tyrosine Kinase
Grace period ended Nov 11, 2026 · lapse expected
 · Low confidence
Pharmacyclics LLCGrace period ended Nov 11, 2026
lapse expected
Low confidence
US 7,718,662Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 7,741,330Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 9,012,463Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 9,278,100Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited